Month: May 2020
-
Symptom App, Algorithm Predict Covid-19 Infections
Data from millions of smartphone app users in the U.K. and U.S. reporting on Covid-19 symptoms show they could estimate a population’s Covid-19 infections.
-
Pharmas License A.I.-Aided Gene Therapies
A university spin-off company designing synthetic viruses with artificial intelligence to deliver gene therapies is licensing its work for eye and muscle disorders.
-
Infographic – Worries Continue About Public Activities
As Covid-19 cases and deaths continue to rise in the U.S., Americans by and large continue to support restrictions on public activity during the pandemic.
-
Stem Cell Therapy Licensed for Genetic Eye Disease
A biotechnology company is licensing its stem cell treatments for retinitis pigmentosa, an inherited eye disease, in a deal valued at $252 million.
-
The behavior of the COVID-19 meta-structure provides the answer to stopping its spread
Matrics2 posits that the Contact Avoidance System is a viable technical solution that if widely used would eliminate all the links in the COVID-19 meta-structure.
-
Phone-Linked Diagnostic Sensor Designed for Covid-19
A university engineering lab is creating a small reusable device connected to a smartphone that detects SARS-CoV-2 viruses in a drop of saliva.
-
Survey Tracking Covid-19 Mental Health Impact
A survey is underway in the U.S. to gauge the mental health impact of the Covid-19 pandemic, with data also collected with personal activity trackers.
-
Vaccine Blocks Suspected Type 1 Diabetes Infections
A candidate vaccine is shown in lab animals to produce a strong immune response against a virus causing a range of diseases, and possibly blocking type 1 diabetes.
-
Synthetic Antibody Limits M.S. Inflammation
An artificial antibody is shown in lab mice to reduce inflammation similar to multiple sclerosis in the brain and activate myelin cells in the spinal cord.
-
[Updated] Fast Paper Strip Covid-19 Test Devised with Crispr
A simple, fast test for Covid-19 infections with treated paper dipped in specimens is being created with the gene-editing technology Crispr.